RE: RE: RE: RE: RE: RE: RE: Bioniche valuation for Your ignorance is off the charts!
The fluff PR's in the last few days show no signs of near term revenue, which is why the stock went nowhere.
Immucodin has strong potential, which is why the stock moved some however its not going to change the company overnight.
The three catalysts for the stock are:
1. Manufacturing Plant: Because the plant can make revenue with or without BNC products
2. Econiche: Strong possibility starting with Canada/International/low probability U.S.
3. Urocidin: 2013
Every other post about valuation is irrelevant because if Urocidin doesn't go anywhere, this stock will be worthless.